Navigation Links
6,000 Turkeys Slaughtered at Czech Bird Flu Farm

Six thousand turkeys at a Czech farm where the potentially lethal H5N1 strain of bird flu was confirmed this week have been slaughtered, officials said on Friday.

"All the turkeys on the farm have been killed and the process is underway for the smaller flocks in the area, around 1,000 birds in all," Czech veterinary services spokesman Zbynek Semerad told AFP.

"That should be completed today (Friday)," he added.

The H5N1 strain of bird flu was confirmed on Thursday at the Tisova farm, in the centre of the country, the first time it has been detected in Czech domestic poultry.

Previous cases of bird flu in the Czech Republic have only affected wild swans.

Czech authorities have imposed a security cordon around the affected farm where disinfection work was continuing on Friday with the help of the army and emergency services.

While Czech authorities remain optimistic that the outbreak will not hit poultry exports, Russia announced Thursday that steps to ban Czech birds, meat, eggs and equipment connected to the poultry industry would be taken within "two to three days".

Czech Agriculture Minister Petr Gandalovic reacted to the threatened Russian ban during a visit to Tisova on Friday.

"It is not possible that international trade is stopped," he said, adding that Prague would seek bilateral negotiations with Moscow with the EU also acting as an intermediary.


'"/>




Page: 1

Related medicine news :

1. Outpatient List Falls From 41,000 To 6,000
2. Pre Implantation Genetic Haplotyping to Identify 6,000 Inherited Diseases
3. Islamabad Culls Over 6,000 Birds Control Bird-flu Outbreak
4. Ham And Turkeys Recalled From Honeybaked Food Company Due To Listeria Scare
5. Hundreds of Turkeys Die Due to Bird Flu
6. Hungarian Geese Slaughtered as Bird Flu Returns to EU
7. Czech Republic struck by fifth bird flu incident
8. H5N1 Bird Flu Confirmed at Czech Turkey Farm

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turkeys Slaughtered Czech Bird Flu Farm

(Date:12/2/2009)... National Pen ( www.pens.com ), a worldwide leadin...t is giving away 10,000 free business card pens. ... -- National Pen ( www.pens.com ), a worldwide lea... it is giving away 10,000 free business card pens....iness that no other company in the industry can do...
(Date:12/2/2009)... National Race Series to increase awareness of pro... the importance of early detection , ... Men, women, families, friends and neighbors &ndas...rticipate in the Rudolph Ramble 5K. The Rudolph R...es , which was launched by the Prostate Condition...
(Date:12/2/2009)... 2 The American Health ...ctors today announced Alan F. Dowling, PhD, will b...alth information management (HIM) leader. Dr. Dow...ludes academia, systems management, strategic expe... executive leadership. He is scheduled to take of...
(Date:12/2/2009)...- 4 State Campaign Features Small Business Owners ...nd Would Kill Jobs ,, WASHINGTON, Dec. 2 /PRNe...summit scheduled for Thursday, Keeping Small Busin...y, today announced a new $1 million 4 state TV ad ...current health care legislation on small business ...
(Date:12/2/2009)... 2 /PRNewswire/ -- The Universities of Sassari a... a team of doctors from the United States, announc...tudy confirming that Pecorino cheese contains high...ga-6 polyunsaturated fatty acid naturally found in...operties for humans. ,, The study, conducted ...
Breaking Medicine News(10 mins):Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3
...er PepsiCo Executive Gary Graves to Join as CEO, ...enters, the largest provider of laser hair removal...nited States, announced it has been acquired by,Ch...izations of middle market companies in partnership...
...AGO, Dec. 10 Corbett Accel Healthcare Group has,s...ran, to serve as its new,Executive Vice President ...ill direct Corbett Accel,s business development st...tive position in,the marketplace. Cooper-Broski wi...
...FAX, Dec. 10 /PRNewswire/ - ImmunoVaccine Technolo...ement company, has signed a binding,memorandum of ...lvania-based biotechnology company developing immu...R),platform with Immunotope,s portfolio of immunot...
...oned Healthcare Industry Executive Adds Depth to M...n Inc.,(Nasdaq: EMAG ), a leader in enterprise me... and health care networks, announced today that Ch...e served in senior executive positions prior to it...
...ve webcast of surgical procedure to be held Thursd.... Eastern Time -, REDWOOD CITY, Calif., Dec. 10 ...t leading cardiac surgeons from The Heart,Hospital...access robotic CABG procedure using innovative ana...
...relationships for those with little memory leave s... experts say , , MONDAY, Dec. 10 (HealthDa... of the life they once knew, some people can still...hild of the Alzheimer,s patient grows to understan...
Other Medicine News:Health News:Private Equity Firms Acquire American Laser Centers 2Health News:CORBETT ACCEL HEALTHCARE GROUP SELECTS ITS CMO: Veteran Brand Builder, Elisa Cooper-Broski, Will Lead Company's Marketing Initiatives 2Health News:ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc. 2Health News:Emageon Names Chris E. Perkins as Chief Operating Officer 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5Health News: Love in the World of Alzheimer's 2Health News: Love in the World of Alzheimer's 3
(Date:12/2/2009)...2 PDL BioPharma, Inc. (P...stablished the per share amount of the previously ...er share. The dividend will be paid on December 15... the December 1, 2009 record date. NASDAQ had prev...of the dividend at $1.67 per share of common stock...
(Date:12/2/2009)... 2 Clarient, Inc. (Nasda...urce for pathologists, oncologists and the pharmac...l Officer transition plan that calls for veteran f...its Senior Vice President and Chief Financial Offi...the current Senior Vice President and Chief Financ...
(Date:12/2/2009)... Dec. 2 Novartis announced today t...on on Tasigna® (nilotinib) 200 mg capsules in...he strength of the company,s hematology portfolio ...data, at the 51st American Society of Hematology (...company,s current therapies and investigational ag...
Breaking Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 1Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 4External beam partial breast irradiation most cost effective treatment 47644 1External beam partial breast irradiation most cost effective treatment 47644 2Researchers call for new space headache category following astronauts survey 47642 1Researchers call for new space headache category following astronauts survey 47642 2
... 20, 2007 /PRNewswire-USNewswire/ -- The,Christoph...,non-profit organization dedicated to finding cure...oving the lives of people living,with paralysis, t...Bush,s veto of the Stem Cell Research Enhancement ...ts in stem cell research with the,support and over...
...RE)--Jun 20, 2007 - Today, President Bush,Signed A...tment To,Research On Pluripotent Stem Cells. Scien...and skill to pursue the potential benefits,of plur...t have the,potential to develop into nearly all th...angering human life in the process. By,expanding s...
Other Medicine Technology:The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 2Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 3
IEC CL31R Multispeed Centrifuge
IEC CL31 Multispeed Centrifuge
IEC CL30 Centrifuge
Automatic Blood Pressure Monitor
Medicine Products: